Alzheimer Disease (AD) is the most common form of dementia in the elderly and currently affects more than four million people In the United States. Identifying the risks associated with the amyloid precursor protein, presenilin 1, presenilin 2, and apolipoprotein E genes has opened new avenues of research but because AD is a complex genetic disorder our understanding of the genetic basis of AD is far from complete. Nearly half of the genetic effect has not been explained and these unidentified genes are keys to defining the cause of this devastating disorder. The present application is a comprehensive effort to integrate statistical (linkage and association studies) and molecular (gene expression studies) genomic approaches toward identifying the remaining AD genes. We recently completed the largest AD genomic screen (455 families, 726 sibpairs) and identified 14 potential regions (MLOD or MLS is greater than or equal too 1.00) as locations for novel AD genes. The most interesting novel region is on 9p22 (MLOD = 3.45; MLS 3.30 in the overall and MLOD = 3.97; MLS = 4.42 in the autopsy confirmed subset[CONF]). We also found evidence supporting the recently reported linkage to chromosome 10q22 (MLOD=2.65; MLS=2.12 in the overall and MLOD=2.94; MLS=1.96 in the CONF). Combined with our continued evidence for a locus on chromosome 12, these three regions represent the highest priority locations for additional AD genes. To perform gene discovery in AD we will: (1) Extend our Family Resources to increase power and develop an independent confirmnation dataset; (2) Identify Locational Candidate Genes by confirming and narrowing the linkage regions and using the human genome sequence to enumerate all the genes within each region; (3) Identify Functional Candidate Genes using microarray and SAGE expression analysis on hippocampal tissue; (4) Test Locational and Functional Candidate Genes using association analyses on a large set of discordant sib pairs. Candidate genes identified through both specific aims 2 (location) and 3 (function) will be given highest priority for detailed examiantion. This approach integrates our family resources and our statistical and molecular expertise to identify the remaining genes in AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG019757-04
Application #
6937659
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Miller, Marilyn
Project Start
2002-09-17
Project End
2007-08-31
Budget Start
2005-09-01
Budget End
2006-08-31
Support Year
4
Fiscal Year
2005
Total Cost
$1,000,692
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23

Showing the most recent 10 out of 66 publications